- Home
- SVRA vs NMCO Comparison
SVRA vs NMCO Comparison
Compare SVRA & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- NMCO
- Stock Information
- Founded
- SVRA 2007
- NMCO 2019
- Country
- SVRA United States
- NMCO United States
- Employees
- SVRA N/A
- NMCO N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- NMCO Finance/Investors Services
- Sector
- SVRA Health Care
- NMCO Finance
- Exchange
- SVRA Nasdaq
- NMCO Nasdaq
- Market Cap
- SVRA 528.3M
- NMCO 565.0M
- IPO Year
- SVRA N/A
- NMCO N/A
- Fundamental
- Price
- SVRA $2.28
- NMCO $10.53
- Analyst Decision
- SVRA Buy
- NMCO
- Analyst Count
- SVRA 7
- NMCO 0
- Target Price
- SVRA $7.57
- NMCO N/A
- AVG Volume (30 Days)
- SVRA 2.5M
- NMCO 207.6K
- Earning Date
- SVRA 05-13-2025
- NMCO 01-01-0001
- Dividend Yield
- SVRA N/A
- NMCO 5.43%
- EPS Growth
- SVRA N/A
- NMCO N/A
- EPS
- SVRA N/A
- NMCO N/A
- Revenue
- SVRA N/A
- NMCO N/A
- Revenue This Year
- SVRA N/A
- NMCO N/A
- Revenue Next Year
- SVRA N/A
- NMCO N/A
- P/E Ratio
- SVRA N/A
- NMCO N/A
- Revenue Growth
- SVRA N/A
- NMCO N/A
- 52 Week Low
- SVRA $1.89
- NMCO $8.52
- 52 Week High
- SVRA $5.11
- NMCO $11.64
- Technical
- Relative Strength Index (RSI)
- SVRA 36.20
- NMCO 59.60
- Support Level
- SVRA $1.89
- NMCO $10.10
- Resistance Level
- SVRA $3.18
- NMCO $10.55
- Average True Range (ATR)
- SVRA 0.21
- NMCO 0.14
- MACD
- SVRA -0.11
- NMCO 0.02
- Stochastic Oscillator
- SVRA 29.77
- NMCO 84.31
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.